| [2-(Cyclohexylamino)-1-[(2S,3R)-3-heptyloxiran-2-yl]-2-oxoethyl] 4-iodobenzoate | IC50 | 7170.0 [1] |
| [2-(Cyclohexylamino)-1-[(2S,3R)-3-heptyloxiran-2-yl]-2-oxoethyl] 4-iodobenzoate | Ki | 1330.0 [1] |
| e-64 | IC50 | 13.0 [1], 16.0 [2], 30.0 [3], 47.0 [4] |
| e-64 | Ki | 30.0 [1] |
| Balicatib | IC50 | 48.0 [1], 503.0 [2] |
| Balicatib | Ki | 503.0 [1], 3260.0 [2], 18000.0 [3] |
| (2R)-N-(Cyanomethyl)-4-methyl-2-[3-(4-piperazin-1-ylphenyl)phenyl]pentanamide | IC50 | 320.0 [1], 2600.0 [2], 3725.0 [3] |
| (2R)-N-(Cyanomethyl)-4-methyl-2-[3-(4-piperazin-1-ylphenyl)phenyl]pentanamide | Ki | 4641.0 [1] |
| L-873724 | IC50 | 264.0 [1], 1221.0 [2] |
| N-(1-((Cyanomethyl)carbamoyl)cyclohexyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide | IC50 | 340.0 [1], 3903.0 [2], 6300.0 [3] |
| N-(1-((Cyanomethyl)carbamoyl)cyclohexyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide | Ki | 6000.0 [1] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-3-methylbenzamide | IC50 | 32.0 [1] |
| N-[(2S)-1-[2-(4-Methoxyanilino)ethylamino]-4-methyl-1-oxopentan-2-yl]-3-methylbenzamide | Ki | 7.0 [1], 7.2 [2], 26.0 [3] |
| Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide | IC50 | 3.0 [1], 5.7 [2], 7.0 [3] |
| Benzyl N-[(2S)-4-methyl-1-[3-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-4-oxopyrrolidin-1-yl]-1-oxopentan-2-yl]carbamate | Ki | 39.0 [1] |
| (2S)-N-(Cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-piperazin-1-ylphenyl)phenyl]ethyl]amino]pentanamide | IC50 | 16.0 [1], 47.0 [2] |
| Benzyl 1-((cyanomethyl)carbamoyl)cyclohexylcarbamate | Ki | 5000.0 [1], 26500.0 [2], 95000.0 [3] |
| 5-Tert-butyl-N-[(2S)-1-(cyanomethylamino)-3-(3-methylphenyl)-1-oxopropan-2-yl]-2-methylpyrazole-3-carboxamide | IC50 | 12.59 [1], 44.0 [2] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide | Ki | 2.2 [1] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(2-morpholin-4-yl-1,3-thiazol-4-yl)benzamide | IC50 | 10000.0 [1], 24000.0 [2] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(2-morpholin-4-yl-1,3-thiazol-4-yl)benzamide | Ki | 74000.0 [1] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-morpholin-4-ylbenzamide | IC50 | 10000.0 [1], 32000.0 [2] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-morpholin-4-ylbenzamide | Ki | 50000.0 [1] |
| N-[(2S)-1-[(3As,6R,6aR)-6-ethynyl-3-oxo-3a,5,6,6a-tetrahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxopentan-2-yl]-4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Ki | 2000.0 [1], 3000.5 [2] |
| N-[(2S)-1-[(3As,6R,6aR)-6-ethynyl-3-oxo-3a,5,6,6a-tetrahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxopentan-2-yl]-4-[5-fluoro-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Ki | 1700.0 [1], 3000.5 [2] |
| Leupeptin | IC50 | 2.5 [1], 6.6 [2] |
| Odanacatib | IC50 | 2995.0 [1], 4843.0 [2] |
| Relacatib | IC50 | 2.0 [1] |
| Relacatib | Ki | 0.07 [1] |
| Z-FY-Cho | IC50 | 0.85 [1] |
| Z-FY-Cho | Ki | 0.47 [1] |
| Pyrrolidine-1-carbonitrile | IC50 | 1584.89 [1], 4000.0 [2] |
| CID 44572423 | Ki | 8400.0 [1] |
| Cathepsin inhibitor 1 | IC50 | 12.59 [1] |
| 1,3-Bis[[n-[(phenylmethoxy)carbonyl]-l-leucyl]amino]-2-propanone | Ki | 340.0 [1] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-piperazin-1-ylphenyl)benzamide | IC50 | 2274.0 [1] |
| N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-piperazin-1-ylphenyl)benzamide | Ki | 7900.0 [1] |
| N-[(2S)-3-Cyclohexyl-1-[2-(4-methoxyanilino)ethylamino]-1-oxopropan-2-yl]-5-[3-(trifluoromethyl)phenyl]furan-2-carboxamide | Ki | 17000.0 [1], 17400.0 [2] |
| (2S)-N-[(1S)-1-Cyano-2-phenylethyl]-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide | IC50 | 67.0 [1], 117.0 [2] |
| Tert-butyl N-[(2S)-1-[2-[2-(2-ethylanilino)-2-oxoethyl]sulfanylcarbonylhydrazinyl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate | IC50 | 56.0 [1] |
| (2S)-1-Phenylpropan-2-yl [(2S)-1-oxohexan-2-yl]carbamate | IC50 | 740.0 [1] |
| CID 44572421 | Ki | 5900.0 [1] |
| (2S)-N-(Cyanomethyl)-4-methyl-2-[[4-(4-piperazin-1-ylphenyl)thiophen-3-yl]amino]pentanamide | IC50 | 352.0 [1] |
| 1-(Phenylmethyl)cyclopentyl[(1S)-1-formylpentyl]carbamate | IC50 | 2000.0 [1] |
| N-[1-[[(2S)-1-Oxo-1-(5-phenyl-1,3,4-oxadiazol-2-yl)pentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 19000.0 [1] |
| N-[1-[[(2S)-1-(5-Ethyl-1,3,4-oxadiazol-2-yl)-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 300.0 [1] |
| N-[1-[[(2S)-1-[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 37000.0 [1] |
| N-[1-[[(2S)-1-Oxo-1-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]pentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 1400.0 [1] |
| Benzyl N-[(2S)-4-methyl-1-oxo-1-[[3-oxo-1-(4-phenoxyphenyl)sulfonylpiperidin-4-yl]amino]pentan-2-yl]carbamate | Ki | 1000.0 [1] |
| Benzyl N-[(2S)-4-methyl-1-[4-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-oxopiperidin-1-yl]-1-oxopentan-2-yl]carbamate | Ki | 16.0 [1] |
| Pyridin-3-ylmethyl N-[(2S)-4-methyl-1-oxo-1-[[(3S)-2-oxo-5-phenyl-1-(3-phenylpropylsulfanyl)pentan-3-yl]amino]pentan-2-yl]carbamate | Ki | 144.4 [1] |
| (2R)-N-(1-Cyanocyclopropyl)-3-(cyclopropylmethylsulfonyl)-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]propanamide | IC50 | 62.0 [1], 188.0 [2] |
| N-[(2S)-3-Naphthalen-2-yl-1-oxo-1-[[(4S)-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]propan-2-yl]naphthalene-1-carboxamide | Ki | 0.43 [1] |
| Benzyl N-[(2S)-1-[[(2S)-4-fluoro-3-oxo-1-phenylbutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate | IC50 | 83.7 [1], 510.0 [2] |
| N-[1-[[(2S)-1-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 1000.0 [1] |
| N-[(1S)-1-[1-[(1S)-1-Cyanopentyl]triazol-4-yl]-1-cyclohexylethyl]thiophene-3-carboxamide | IC50 | 10000.0 [1], 20000.0 [2] |
| N-[(1S)-1-[1-[(1S)-1-Cyanopentyl]triazol-4-yl]-1-(4-methylcyclohexyl)ethyl]thiophene-3-carboxamide | IC50 | 15000.0 [1], 20000.0 [2] |
| CID 16108900 | IC50 | 1.1 [1], 1100.0 [2] |
| (2R)-N-(1-Cyanocyclopropyl)-3-methylsulfonyl-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]propanamide | IC50 | 230.0 [1], 1013.0 [2] |
| (2R)-2-[[(1S)-1-(4-Bromophenyl)-2,2,2-trifluoroethyl]amino]-N-(1-cyanocyclopropyl)-3-methylsulfonylpropanamide | IC50 | 427.0 [1], 430.0 [2] |
| 6-[[4-(4-Acetylpiperazin-1-yl)phenoxy]methyl]-7-(2-cyclohexylethyl)pyrrolo[2,3-d]pyrimidine-2-carbonitrile | IC50 | 4000.0 [1], 5200.0 [2] |
| Benzyloxycarbonyl-leucyl-methionine-H | IC50 | 5.0 [1] |
| Benzyloxycarbonyl-leucyl-methionine-H | Ki | 1.3 [1] |
| N-[(2S)-3-(3-Chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl]benzamide | IC50 | 251.19 [1] |
| N-[1-[[(2S)-1-(5-Methoxy-1,3,4-oxadiazol-2-yl)-1-oxopentan-2-yl]carbamoyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | Ki | 160.0 [1] |
| N-[(2S)-4-Methyl-1-oxo-1-[[(4S)-3-oxo-1-[2-(3-pyridin-2-ylphenyl)acetyl]azepan-4-yl]amino]pentan-2-yl]-5-(2-morpholin-4-ylethoxy)-1-benzofuran-2-carboxamide | Ki | 0.49 [1], 1.2 [2] |
| 6-(Cyclohexylamino)-9-[2-(4-methylpiperazin-1-YL)-ethyl]-9H-purine-2-carbonitrile | IC50 | 89.0 [1] |
| [(E)-[(3-Bromophenyl)-(3-hydroxyphenyl)methylidene]amino]thiourea | IC50 | 131.4 [1] |
| [(E)-[(3-Bromophenyl)-(3-hydroxyphenyl)methylidene]amino]thiourea | Ki | 3.7 [1] |
| (1R,2R)-N-(Cyanomethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexane-1-carboxamide | IC50 | 10000.0 [1], 100000.0 [2] |
| (1r,2r)-N-(1-Cyanocyclopropyl)-2-{[4-(4-Fluorophenyl)piperazin-1-Yl]carbonyl}cyclohexanecarboxamide | IC50 | 10000.0 [1], 100000.0 [2] |
| (3S)-19-Chloro-N-(1-cyanocyclopropyl)-5-oxo-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(20),6(11),7,9,18,21-hexaene-3-carboxamide | IC50 | 50.0 [1] |
| (3S)-19-Chloro-N-(1-cyanocyclopropyl)-5-oxo-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(20),6(11),7,9,18,21-hexaene-3-carboxamide | Ki | 10.0 [1] |
| (2R)-N'-Hydroxy-2-(2-methylpropyl)-N-[(2S)-1-oxo-1-[[(2S)-1-oxopropan-2-yl]amino]-3-phenylpropan-2-yl]butanediamide | IC50 | 15.0 [1], 25.0 [2] |
| [(E)-[(3,5-Dibromophenyl)-(3-hydroxyphenyl)methylidene]amino]thiourea | IC50 | 202.0 [1] |
| [(E)-[(3,5-Dibromophenyl)-(3-hydroxyphenyl)methylidene]amino]thiourea | Ki | 8.4 [1] |
| 4-[1,3-Benzodioxol-5-ylmethyl-[4-(trifluoromethyl)cyclohexyl]amino]-5-fluoropyrimidine-2-carbonitrile | Ki | 3500.0 [1], 5100.0 [2] |
| N-(Cyanomethyl)-8-hydroxy-5-nitroquinoline-7-carboxamide | Ki | 155000.0 [1] |
| (2S,3R)-N-[(2R)-1-(1H-Indol-3-yl)-3-oxopropan-2-yl]-3-methyl-2-(naphthalen-1-ylsulfonylamino)pentanamide | IC50 | 1.9 [1], 2.0 [2] |
| 2-(4-Butylphenyl)-1H-quinolin-4-one | IC50 | 1600.0 [1] |
| 2-(4-Butylphenyl)-1H-quinolin-4-one | Ki | 1500.0 [1] |
| 3-Phenylmethoxy-10H-acridin-9-one | IC50 | 3900.0 [1] |
| 3-Phenylmethoxy-10H-acridin-9-one | Ki | 900.0 [1] |
| 2-Nitro-7-phenylmethoxy-10H-acridin-9-one | IC50 | 500.0 [1] |
| 2-Nitro-7-phenylmethoxy-10H-acridin-9-one | Ki | 200.0 [1] |
| 3-(3-Methoxy-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | IC50 | 2100.0 [1] |
| 3-(3-Methoxy-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | Ki | 1900.0 [1] |
| 3-(3-Nitro-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | IC50 | 2900.0 [1] |
| 3-(3-Nitro-4-phenylmethoxyanilino)naphthalene-2-carboxylic acid | Ki | 1900.0 [1] |
| (3S,14E)-19-Chloro-N-(1-cyanocyclopropyl)-5-oxo-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(20),6(11),7,9,14,18,21-heptaene-3-carboxamide | IC50 | 47.7 [1] |
| (3S,14E)-19-Chloro-N-(1-cyanocyclopropyl)-5-oxo-9-(trifluoromethyl)-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(20),6(11),7,9,14,18,21-heptaene-3-carboxamide | Ki | 2.4 [1] |
| (3S)-23-Chloro-N-(1-cyanocyclopropyl)-5-oxo-16,21-dioxa-4-azatetracyclo[20.2.2.06,15.08,13]hexacosa-1(24),6(15),7,13,22,25-hexaene-3-carboxamide | IC50 | 13.0 [1] |
| (3S)-23-Chloro-N-(1-cyanocyclopropyl)-5-oxo-16,21-dioxa-4-azatetracyclo[20.2.2.06,15.08,13]hexacosa-1(24),6(15),7,13,22,25-hexaene-3-carboxamide | Ki | 3.0 [1] |
| [(E)-[[3-(3-Methylbenzoyl)phenyl]-(3-methylphenyl)methylidene]amino]thiourea | IC50 | 654.0 [1], 7823.0 [2] |
| [(E)-[[3-(4-Propan-2-yloxybenzoyl)phenyl]-(4-propan-2-yloxyphenyl)methylidene]amino]thiourea | IC50 | 10000.0 [1] |
| N-[(2S)-1-(Cyanomethylamino)-3-cyclohexyl-1-oxopropan-2-yl]benzamide | IC50 | 55.0 [1], 230.0 [2] |
| N-[(2S)-1-[(6R)-6-Ethynyl-3-oxo-3a,5,6,6a-tetrahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxopentan-2-yl]-3-fluoro-4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Ki | 750.5 [1], 1400.0 [2] |
| Ethyl acetate | IC50 | 10000.0 [1] |
| Pepstatin | IC50 | 800.0 [1] |
| Telaprevir | IC50 | 3500.0 [1] |